兴图新科2月2日获融资买入1084.10万元，融资余额1.57亿元

Group 1 - The core viewpoint of the news is that Xingtou New Science has shown significant trading activity and financial performance, with a notable increase in revenue but a net loss in profit [1][2]. - On February 2, Xingtou New Science's stock rose by 2.45%, with a trading volume of 73.13 million yuan. The financing buy-in amount was 10.84 million yuan, while the financing repayment was 10.75 million yuan, resulting in a net financing buy of 88,800 yuan [1]. - As of February 2, the total financing and securities balance for Xingtou New Science was 157 million yuan, which represents 4.33% of its circulating market value, indicating a high level of financing compared to the past year [1]. Group 2 - As of September 30, the number of shareholders for Xingtou New Science increased to 6,426, a rise of 30.24%, while the average circulating shares per person decreased by 23.22% to 16,034 shares [2]. - For the period from January to September 2025, Xingtou New Science reported operating revenue of 91.23 million yuan, reflecting a year-on-year growth of 31.99%. However, the net profit attributable to the parent company was a loss of 44.74 million yuan, a decrease of 5.71% compared to the previous year [2]. - Since its A-share listing, Xingtou New Science has distributed a total of 33.12 million yuan in dividends, with no dividends paid in the last three years [3].